tiprankstipranks
Advertisement
Advertisement

MosChip Board Clears Q3 FY26 Results, Expands Employee Stock Option Allotments

Story Highlights
  • MosChip’s board approved unaudited Q3 FY26 financial results under Ind-AS standards.
  • The company allotted new equity shares and granted ESOPs, deepening employee ownership plans.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
MosChip Board Clears Q3 FY26 Results, Expands Employee Stock Option Allotments

Meet Samuel – Your Personal Investing Prophet

Moschip Technologies Ltd ( (IN:MOSCHIP) ) has shared an announcement.

MosChip Technologies’ board has approved the company’s unaudited standalone and consolidated financial results for the quarter ended 31 December 2025, prepared under Indian Accounting Standards and reviewed by its statutory auditors and audit committee, with the results to be published on its website and in English and Telugu newspapers. In the same meeting, the board’s Nomination & Remuneration Committee approved the allotment of 195,909 equity shares to employees upon exercise of vested stock options and granted a further 903,130 employee stock options under existing ESOP schemes, signalling continued emphasis on employee ownership and alignment with long-term performance.

More about Moschip Technologies Ltd

MosChip Technologies Limited is an Indian technology company based in Hyderabad, operating in the semiconductor and electronics design space, with a focus on providing chip design, embedded systems and related engineering solutions to global and domestic clients.

Average Trading Volume: 230,559

Technical Sentiment Signal: Buy

Current Market Cap: 40.47B INR

For a thorough assessment of MOSCHIP stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1